Medochemie

Established in 1976, Medochemie is a global pharmaceutical company headquartered in Cyprus, driven by a mission to provide accessible, high-quality drug treatments worldwide. Operating within the Pharmaceuticals and Healthcare industries, the company focuses on developing, licensing, manufacturing, marketing, and distributing branded generic, super-generic, and patented pharmaceutical products. Medochemie's extensive product portfolio spans over 10 therapeutic categories, encompassing 630 different pharmaceutical products for which it holds 3,800 marketing authorization licenses. The company adheres to the strictest quality standards, fully complying with European guidelines in all its operations.

Medochemie has strategically expanded its reach from Europe to the Middle East & Africa and the Far East, enabling operations in 106 countries through a network of agents and partners, in addition to its 20 core offices. The company boasts thirteen manufacturing plants and facilities, with nine located in Cyprus, one in the Netherlands, and three in Vietnam. This robust infrastructure supports its commitment to delivering pharmaceutical solutions globally. The company's revenue stands at $322.3M, reflecting its significant market presence and operational scale.

The driving force behind Medochemie's success is its 1,370 multinational, talented, and quality-focused employees. These individuals contribute to the company's operations across its manufacturing plants and offices worldwide. Medochemie is a founding member of Medicines for Europe, underscoring its commitment to industry collaboration and advancement. To learn more about the people behind the company's achievements, you can Meet Medochemie's team.